ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Antiviral Activity of Hellenia speciosa (J. Koenig) S.R. Dutta Rhizome Metabolites Against Human Adenovirus: Insights from Molecular Docking and In Vitro Studies
Provisionally accepted- 1Department of Biological sciences, Faculty of Science, King Abdulaziz University, jeddah, Saudi Arabia
- 2Center of ScientiFIc Excellence for Influenza Viruses, Environmental Research Division, National Research Centre (NRC), 12622, Cairo, Egypt
- 3Medical Laboratory, King Abdulaziz University Hospital, King Abdulaziz University, jeddah, Saudi Arabia
- 4Virology laboratory, Lab specialist , King Abdulaziz University Hospital, jeddah, Saudi Arabia
- 5The Applied College , University of Jeddah, jeddah, Saudi Arabia
- 6Chemistry Department, Faculty of Applied Science, Taiz University, Taiz, Yemen
- 7Microbiology Department, Pathology and Laboratory Medicine, Prince Mohammed Bin Abdulaziz Hospital tal PMBAH, Medina, Saudi Arabia
- 8Department of Medical Laboratory Sciences, Faculty of Applied Medical Science, King Abdulaziz University, Jeddah, Saudi Arabia
- 9Department of Biology, Faculty of Education, Albaydha University, Al-Baydha, Yemen
- 10Laboratory Department ,University Medical Services Center, King Abdulaziz University, 21589, Jeddah, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Word count: 162 Abstract Background: Human adenoviruses (HAdVs) cause a wide range of clinical diseases, yet effective antiviral therapies remain limited. Natural products, particularly medicinal plants, offer potential sources of antiviral agents. Purpose: This study aimed to evaluate the antiviral potential of Hellenia speciosa (J.Koenig) S.R.Dutta [syn. Costus speciosus (J.Koenig) Sm.; Costaceae] rhizome against HAdVs using both in vitro and in silico approaches. Methods: Rhizome extracts were tested on Vero cells to assess cytotoxicity and antiviral activity. GC–MS identified bioactive metabolites, which were screened against adenoviral DNA polymerase using molecular docking. Results: Docking predicted strong interactions of selected metabolites with the viral polymerase, guiding selection for in vitro assays. The methanolic extract exhibited low cytotoxicity and potent antiviral effects, while the ethanolic extract also showed notable activity. Selectivity indices indicated a favorable therapeutic window. Conclusion: H. speciosa rhizome contains bioactivemetabolites with potential anti-adenoviral activity. While preliminary results are promising, further in vivo and clinical studies are required to confirm pharmacological relevance.
Keywords: Human adenoviruses, Hellenia speciosa (syn. Costus speciosus), Antiviral pharmacological effects, molecular docking, GC–MS, drug-likeness, Metabolites
Received: 18 Aug 2025; Accepted: 03 Dec 2025.
Copyright: © 2025 ALNHHAS, Bouback, Albeshri, Alsahafi, Al-Sarraj, Al-sulaimany, Ali, Moatasim, Kutkat, Gaballah, Badierah, Taibah, Almulaiky, Al-zughaibi, Mufrrih, Al-Maaqar and Fathuldeen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
SARA ALNHHAS
Thamer Bouback
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
